PerkinElmer's Q1 Revenues Climb 14 Percent on Human Health Segment Strength | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer's first-quarter revenues rose 14 percent year over year with particular strength in its Human Health segment, the company reported after the close of the market on Thursday.

For the three months ended April 1, total revenues were $510.9 million, up from $447.2 million a year ago, and nudging past analyst estimates of $510.4 million. Organically, revenues increased 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.